Dietary advanced glycation end products (AGEs) and their interactions with the receptor for AGEs (RAGE) may play a role in the pathogenesis of type 1 diabetes. This study set out to assess whether there is any association between circulating concentrations of soluble RAGE (sRAGE), AGEs, and their ratio with the appear-ance of diabetes-associated autoantibodies in children progressing to clinical diabetes. RESEARCH DESIGN AND METHODS Serum concentrations of sRAGE,N-«(carboxymethyl)lysine (CML) adducts and the sRAGE/CML ratio were analyzed in children who progressed to type 1 diabetes. The samples were taken at four time points: before seroconversion, at the time of the first autoantibody-positive sample, at the time of the first sample posit...
Advanced glycation end products (AGEs) and their receptors are strongly implicated in the developmen...
The sRAGE [soluble RAGE (receptor for advanced glycation end-products)] lack the transmembrane and c...
AIM: Advanced glycation end products (AGEs) and/or their receptors (RAGE) are significantly positive...
OBJECTIVE Dietary advanced glycation end products (AGEs) and their interactions with the receptor fo...
Background: Advanced glycation end products (AGEs) and their interaction with the receptor for AGEs ...
The globally rising incidence of Type 1 diabetes (T1D) is no longer restricted to individuals with h...
Background Advanced glycation end products (AGEs) play a role in the development of ...
Advanced glycation end products, AGEs, and its specific receptor, RAGE, are involved in vascular com...
Aims/hypothesis: This group of studies examines human genetic susceptibility conferred by the recept...
We analyzed the relationship among soluble receptor for advanced glycation end products (sRAGEs), th...
Isoforms of the receptor for advanced glycation end-product (RAGE) protein, which lack the transmemb...
OBJECTIVE: We analyzed the relationship among soluble receptor for advanced glycation end products (...
We analyzed the relationship among soluble receptor for advanced glycation end products (sRAGEs), th...
Background: The receptors for advanced glycation end products (RAGE) are increased in atheroscleroti...
The receptor for advanced glycation end products (RAGE), a well-known player of diabetes mellitus (D...
Advanced glycation end products (AGEs) and their receptors are strongly implicated in the developmen...
The sRAGE [soluble RAGE (receptor for advanced glycation end-products)] lack the transmembrane and c...
AIM: Advanced glycation end products (AGEs) and/or their receptors (RAGE) are significantly positive...
OBJECTIVE Dietary advanced glycation end products (AGEs) and their interactions with the receptor fo...
Background: Advanced glycation end products (AGEs) and their interaction with the receptor for AGEs ...
The globally rising incidence of Type 1 diabetes (T1D) is no longer restricted to individuals with h...
Background Advanced glycation end products (AGEs) play a role in the development of ...
Advanced glycation end products, AGEs, and its specific receptor, RAGE, are involved in vascular com...
Aims/hypothesis: This group of studies examines human genetic susceptibility conferred by the recept...
We analyzed the relationship among soluble receptor for advanced glycation end products (sRAGEs), th...
Isoforms of the receptor for advanced glycation end-product (RAGE) protein, which lack the transmemb...
OBJECTIVE: We analyzed the relationship among soluble receptor for advanced glycation end products (...
We analyzed the relationship among soluble receptor for advanced glycation end products (sRAGEs), th...
Background: The receptors for advanced glycation end products (RAGE) are increased in atheroscleroti...
The receptor for advanced glycation end products (RAGE), a well-known player of diabetes mellitus (D...
Advanced glycation end products (AGEs) and their receptors are strongly implicated in the developmen...
The sRAGE [soluble RAGE (receptor for advanced glycation end-products)] lack the transmembrane and c...
AIM: Advanced glycation end products (AGEs) and/or their receptors (RAGE) are significantly positive...